Board of Directors

Born in 1949. Board Vice Chairman. Elected to the Board in 2003. BioGaia Board Chairman 2007–2018. MBA from the Stockholm School of Economics. Marketing and PR consultant. President of Innoventive Partners LLC. Former Executive Vice President and Marketing Director at Philip Morris USA and Philip Morris International. Other board assignments: New York City Ballet Inc., School of Creative Leadership, Berlin University and Swedish-American Chamber of Commerce (chairman 1997–2001). Holds 1,750,000 class B shares.

Born in 1956. Elected to the Board in 2023. Certified physician with a specialty in Ob&Gyn from the University of Umeå and a doctorate in Reproductive Physiology from the University of Gothenburg. Has upheld a number of leading positions in Swedish healthcare as head of departments both in public and private practice. Previously Managing Director for the Children’s Hospital at Karolinska University Hospital, Stockholm, and CEO for the Sahlgrenska University Hospital, Gothenburg. Other current board assignments: Getinge AB, Apoteket AB, WeMind AB, Sophiahemmet, Bräcke Diakoni and the Swedish Sea and Rescue Organisation. Holds 500 class B shares.

Born in 1967. Elected to the Board in 2023. Holds a master’s degree in Agriculture Economics at the University of Helsinki, MBA from the University of Arkansas and has also studied psychology at Yale University. Outi has worked with global marketing in senior positions within areas such as life science, nutrition & health, food and agriculture within companies such as P&G, SGS and DSM in Switzerland. Outi is currently Chief Commercial and Marketing Officer at Medicel, a company of Halma Plc. Holds 0 shares.

Born in 1980. Elected to the Board in 2015. Holds a bachelor’s degree in Management and Systems from City, University of London and a master’s degree in Financial Management from the University of Cape Town. Former Chief Operating Officer Fund Linked Products at Credit Suisse Investment Bank, London. Other board assignments: Infant Bacterial Therapeutics AB (IBT). Holds 2,890 class B shares.

Born in 1986. Elected to the Board in 2020. Bachelor’s degree in International Economics and Management from University L. Bocconi in Milan and has also studied business and market strategy and decision psychology at the business school HEC in Paris. Previously worked as Regional Sales Manager at BioGaia, COO at Iero, and has held various senior strategic positions within sustainable business development at the H&M Group. Holds 160 class B shares.

Born in 1973. Elected to the Board in 2022. Has a Master of Administration from the University of Bath, a PhD from the National Institute of Agronomic in France and a Master in Corporate Entrepreneurial Leadership from the Technology Economics & Management in Denmark. Has held several senior positions in the health and agriculture industries and worked in senior positions with pharmaceuticals, health products and consumer goods, among others. Since 2019, Bénédicte Flambard is Global Head of Plant Health Business at FMC Corp. and stationed in Denmark. Other board assignments: Noscomed and Anizome. Holds 0 shares.

Born in 1979. Elected to the Board in 2023. Holds a M.Sc. (Econ.) degree with a major in Finance from the Helsinki School of Economics. Partner at EQT Partners. Board member of Desotec, Bluestep Holding AB and Oterra. Previous assignments include Board member of BHG Group, Vitrolife, Kfzteile24, Elevate, Igenomix, Musti Group, Karo Pharma, Terveystalo, Vertu, Roeser Group, Swiss Smile, VTI Technologies and Lundhags. Holds 0 shares.